144 related articles for article (PubMed ID: 1540874)
1. Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple Myeloma.
Luoni R; Ucci G; Riccardi A; Gobbi P; Avato FM; Vignale C; Ascari E
Cancer; 1992 Mar; 69(6):1368-72. PubMed ID: 1540874
[TBL] [Abstract][Full Text] [Related]
2. Serum thymidine kinase and beta-2 microglobulin in monoclonal gammopathies.
Ucci G; Riccardi A; Luoni R; Spriano P; Merlini G; Danova M; Cassano E; Molinari E; Ascari E
Tumori; 1987 Oct; 73(5):445-9. PubMed ID: 3318049
[TBL] [Abstract][Full Text] [Related]
3. Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.
Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):3025-9. PubMed ID: 9329592
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between plasma cell thymidine labelling index and serum beta-2-microglobulin in monoclonal gammopathies.
Boccadoro M; Durie BG; Frutiger Y; Gavarotti P; Redoglia V; Massaia M; D'Alberto M; Marmont F; Gallamini A; Tribalto M
Acta Haematol; 1987; 78(4):239-42. PubMed ID: 3122489
[TBL] [Abstract][Full Text] [Related]
5. Analysis of thymidine kinase serum levels by novel method DiviTum in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT.
Bacovsky J; Myslivecek M; Minarik J; Scudla V; Pika T; Zapletalova J; Petrova P; Bartkova M; Adam T; Gronowitz SJ
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):135-8. PubMed ID: 24572488
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma.
Greipp PR; Lust JA; O'Fallon WM; Katzmann JA; Witzig TE; Kyle RA
Blood; 1993 Jun; 81(12):3382-7. PubMed ID: 8507875
[TBL] [Abstract][Full Text] [Related]
7. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
Boccadoro M; Gavarotti P; Fossati G; Pileri A; Marmont F; Neretto G; Gallamini A; Volta C; Tribalto M; Testa MG
Br J Haematol; 1984 Dec; 58(4):689-96. PubMed ID: 6518137
[TBL] [Abstract][Full Text] [Related]
8. Serum deoxythymidine kinase: no help in the diagnosis and prognosis of monoclonal gammopathy.
Bäck H; Jagenburg R; Rödjer S; Westin J
Br J Haematol; 1993 Aug; 84(4):746-8. PubMed ID: 8217837
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.
Riccardi A; Ucci G; Luoni R; Castello A; Coci A; Magrini U; Ascari E
J Clin Pathol; 1990 Jun; 43(6):469-75. PubMed ID: 2199532
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma.
Musolino C; Allegra A; Orlando A; Grosso P; Alonci A; Cincotta M; Squadrito G
Riv Eur Sci Med Farmacol; 1990; 12(4-5):233-8. PubMed ID: 2103961
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
[TBL] [Abstract][Full Text] [Related]
12. Presenting features of monoclonal gammopathies: an analysis of 684 newly diagnosed cases. Cooperative Group for the Study and Treatment of Multiple Myeloma.
Ucci G; Riccardi A; Luoni R; Ascari E
J Intern Med; 1993 Aug; 234(2):165-73. PubMed ID: 8340739
[TBL] [Abstract][Full Text] [Related]
13. Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders.
Garewal H; Durie BG; Kyle RA; Finley P; Bower B; Serokman R
J Clin Oncol; 1984 Jan; 2(1):51-7. PubMed ID: 6366146
[TBL] [Abstract][Full Text] [Related]
14. Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma.
Greipp PR; Kyle RA
Blood; 1983 Jul; 62(1):166-71. PubMed ID: 6407546
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.
Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):3021-4. PubMed ID: 9329591
[TBL] [Abstract][Full Text] [Related]
16. [Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
Milanesi B; Tafuri C; Perini M; Rota G; Peretti P
Quad Sclavo Diagn; 1984 Jun; 20(2):149-54. PubMed ID: 6528014
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
Schambeck CM; Wick M; Bartl R; Lamerz R; Fateh-Moghadam A
J Clin Pathol; 1995 May; 48(5):477-81. PubMed ID: 7629298
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
[TBL] [Abstract][Full Text] [Related]
19. Histologic, biochemical, and clinical parameters for monitoring multiple myeloma.
Bartl R; Frisch B; Diem H; Mündel M; Nagel D; Lamerz R; Fateh-Moghadam A
Cancer; 1991 Nov; 68(10):2241-50. PubMed ID: 1913461
[TBL] [Abstract][Full Text] [Related]
20. [Serum thymidine kinase in multiple myeloma: I. Relation to selected laboratory indicators in the disease].
Scudla V; Bacovský J; Papajík T; Budíková M; Srovnalík K
Vnitr Lek; 1994 Mar; 40(3):151-6. PubMed ID: 8184566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
